A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
Clinical trial NCT01709734 · TERMINATED
Trial details
- NCT number
- NCT01709734
- Sponsor
- LTN PHARMACEUTICALS, INC.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.